ST Pharm is a top-tier CDMO with an integrated technology platform supporting clinical- and commercial-scale production of next-generation therapeutic oligonucleotides, mRNA vaccines, and mRNA therapeutics. Our nucleic acid platform includes process development, analytical development, and manufacturing services that are enhanced by the supply of critical raw materials such as nucleotides, phosphoramidites, and capping reagents, as well as leading RNA delivery solutions including lipid nanoparticles. At ST Pharm, we are wholly committed to advancing life-saving nucleic acid medicines for patients around the world.